Page last updated: 2024-08-16

risperidone and lorazepam

risperidone has been researched along with lorazepam in 48 studies

Research

Studies (48)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (10.42)18.2507
2000's26 (54.17)29.6817
2010's12 (25.00)24.3611
2020's5 (10.42)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY2
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Emes, CE; Millson, RC1
Zimbroff, DL1
Hillard, JR1
Bouman, NH; Dhossche, DM1
Chang, WH; Lane, HY; Su, KP1
Bader, PI; Cangany, N; Dougherty, S; Jackson, CE; Raymond, G1
Currier, GW; Simpson, GM1
Coletti, DJ; Dicker, R; Kafantaris, V; Kane, JM; Padula, G1
Beijnen, JH; Kerbusch, T; Mathôt, RA; Meesters, EW; Otten, HM; Schellens, JH; van Kan, HJ1
Cherry, D; Cummings, JL; Frank, JC; Hewett, L; Kemp, B; Kohatsu, ND; Mittman, B1
Allain, H; Bentué-Ferrer, D; Bouhours, P; Gandon, M; Le Breton, S; Tarral, A; Tessier, C1
Augustyns, I; Grossman, F; Ravindran, A; Vieta, E; Yatham, LN1
Bossie, CA; Chou, JC; Currier, GW; Feifel, D; Gharabawi, GM; Mahmoud, RA; Turkoz, I1
Chrzanowski, W; Karavatos, A; Larmo, I; Lejeune, J; Lex, A; Medori, R; Schreiner, A; Witte, R1
Englert, I1
Eerdekens, M; Grossman, F; Karcher, K; Khanna, S; Kramer, M; Smulevich, AB1
Dries, PJ; Hovens, JE; Loonen, AJ; Melman, CT; Wapenaar, RJ1
Currier, GW; McMullan, JT; Veser, BD; Veser, FH; Zealberg, J1
Arai, H; Hatta, K; Miyakawa, K; Nakamura, H; Ota, T; Usui, C1
Emsley, R; Koen, L; Medori, R; Niehaus, DJ; Oosthuizen, PP; Rabinowitz, J1
Athey, R; Forlano, R; Singh, D1
Casteels, M; de Vos, M; Laekeman, G; Reyntens, J; Zwaenepoel, L1
Kutscher, E; Peterson, E; Stoebner, A; Weatherill, J1
Bansal, V; Gupta, S; Kumar, S; Mowar, A; Sharma, S1
Fornaro, G; Ghio, L; Rossi, P1
Böker, H; Krähenmann, R; Küchenhoff, B; Schick, M1
Behere, RV; Danivas, V; Gangadhar, BN; Rao, NP; Varambally, S; Venkatasubramanian, G1
Fajardo, K; Grenier, E; John, V; Ko, E; Ryan, M1
Askenazy, F; Drici, M; Lavrut, T; Menard, ML; Yagoubi, F1
Kar, SK; Saxena, S; Trivedi, JK1
Csomor, PA; Geyer, MA; Huber, T; Preller, KH; Studerus, E; Vollenweider, FX1
Guru, S; Loganathan, S; Vanamoorthy, U; Varghese, M1
Erkuran, HÖ; Kutlu, A; Önen, Ö1
Aggarwal, N; Kataria, D; Prakash, R; Prasad, S1
Hernández-Salas, LP; Herrera-Huerta, CA; Magallanes-Cano, EM1
Barbe, N; Coffey, BJ; Miller, M; Poulsen, RJ1
Al Abdulla, M; Haddad, PM; Iqbal, Y; Latoo, J1
Faisal, M; O'Hanrahan, S; Pradeep, V1
Acheampong, D; Cardieri, B; Coffey, BJ; Crow, M; Rice, T1

Reviews

3 review(s) available for risperidone and lorazepam

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Emergency treatment of acute psychosis.
    The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 1

    Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Clozapine; Decision Trees; Drug Administration Schedule; Emergency Services, Psychiatric; Emergency Treatment; Haloperidol; History, 20th Century; Humans; Lorazepam; Olanzapine; Pirenzepine; Psychotic Disorders; Risperidone

1998
Guidelines for managing Alzheimer's disease: Part II. Treatment.
    American family physician, 2002, Jun-15, Volume: 65, Issue:12

    Topics: Advance Directives; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Disease Progression; Donepezil; Humans; Indans; Lorazepam; Patient Education as Topic; Phenylcarbamates; Piperidines; Risperidone; Rivastigmine

2002

Trials

8 trial(s) available for risperidone and lorazepam

ArticleYear
Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers.
    Psychopharmacology, 2003, Volume: 165, Issue:4

    Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Cognition; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Electrooculography; Female; Humans; Lorazepam; Male; Memory; Psychomotor Performance; Risperidone

2003
Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial.
    The British journal of psychiatry : the journal of mental science, 2003, Volume: 182

    Topics: Adult; Aged; Antimanic Agents; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Brief Psychiatric Rating Scale; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lithium Compounds; Lorazepam; Male; Middle Aged; Psychiatric Status Rating Scales; Risperidone; Treatment Outcome; Treatment Refusal; Valproic Acid

2003
Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam.
    The Journal of clinical psychiatry, 2004, Volume: 65, Issue:3

    Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Cluster Analysis; Drug Therapy, Combination; Female; Haloperidol; Humans; Injections, Intramuscular; Lorazepam; Male; Middle Aged; Prospective Studies; Psychomotor Agitation; Risperidone; Severity of Illness Index; Single-Blind Method

2004
Oral risperidone plus oral lorazepam versus standard care with intramuscular conventional neuroleptics in the initial phase of treating individuals with acute psychosis.
    International clinical psychopharmacology, 2004, Volume: 19, Issue:5

    Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Aggression; Antipsychotic Agents; Basal Ganglia Diseases; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Lorazepam; Male; Middle Aged; Psychotic Disorders; Risperidone; Schizophrenia; Treatment Outcome

2004
Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2005, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Bipolar Disorder; Dopamine Antagonists; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Haloperidol; Humans; Lorazepam; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Risperidone; Serotonin Antagonists; Time Factors; Treatment Outcome

2005
Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study.
    Journal of psychopharmacology (Oxford, England), 2005, Volume: 19, Issue:1

    Topics: Adolescent; Adult; Aged; Aggression; Anti-Anxiety Agents; Antipsychotic Agents; Clopenthixol; Drug Therapy, Combination; Emergency Medical Services; Endpoint Determination; Female; Humans; Lorazepam; Male; Middle Aged; Personnel, Hospital; Prospective Studies; Psychiatric Status Rating Scales; Psychomotor Performance; Psychotic Disorders; Risperidone; Social Behavior

2005
Risperidone versus haloperidol, in combination with lorazepam, in the treatment of acute agitation and psychosis: a pilot, randomized, double-blind, placebo-controlled trial.
    Journal of psychiatric practice, 2006, Volume: 12, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Anxiety Agents; Antipsychotic Agents; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Haloperidol; Humans; Lorazepam; Male; Middle Aged; Pilot Projects; Prospective Studies; Psychomotor Agitation; Risperidone; Severity of Illness Index; Treatment Outcome

2006
Long-acting injectable risperidone in the treatment of subjects with recent-onset psychosis: a preliminary study.
    Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:2

    Topics: Adolescent; Adult; Antidepressive Agents; Blood Glucose; Body Mass Index; Cholesterol; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Injections; Lorazepam; Male; Pilot Projects; Prolactin; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Severity of Illness Index; Time Factors; Treatment Outcome; Weight Gain

2008

Other Studies

37 other study(ies) available for risperidone and lorazepam

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
    Journal of medicinal chemistry, 2001, Jul-19, Volume: 44, Issue:15

    Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water

2001
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
    Journal of medicinal chemistry, 2002, Jun-20, Volume: 45, Issue:13

    Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding

2002
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
    Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5

    Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
    Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24

    Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility

2010
Risperidone-induced priapism.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1994, Volume: 39, Issue:5

    Topics: Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Humans; Isoxazoles; Lithium Carbonate; Lorazepam; Male; Middle Aged; Piperidines; Priapism; Risperidone; Schizophrenia, Paranoid

1994
Switching patients from clozapine to risperidone therapy.
    The American journal of psychiatry, 1995, Volume: 152, Issue:7

    Topics: Antipsychotic Agents; Clonazepam; Clozapine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoxazoles; Lorazepam; Piperidines; Risperidone; Schizophrenia; Substance Withdrawal Syndrome

1995
Catatonia in an adolescent with Prader-Willi Syndrome.
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 1997, Volume: 9, Issue:4

    Topics: Adolescent; Antipsychotic Agents; Catatonia; Haloperidol; Humans; Lorazepam; Male; Neurologic Examination; Neuropsychological Tests; Prader-Willi Syndrome; Risperidone; Treatment Outcome

1997
Seizures after discontinuation of low-dose lorazepam from originally seizure-free clozapine regimen: combined effects?
    The Journal of clinical psychiatry, 1999, Volume: 60, Issue:6

    Topics: Adult; Anti-Anxiety Agents; Clozapine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electroencephalography; Humans; Lorazepam; Male; Risperidone; Schizophrenia; Seizures; Substance Withdrawal Syndrome

1999
Infantile refsum disease in four Amish sibs.
    American journal of medical genetics, 2000, Jan-17, Volume: 90, Issue:2

    Topics: Adolescent; Antidepressive Agents; Child; Consanguinity; Female; Fluoxetine; Humans; Lorazepam; Male; Refsum Disease; Risperidone

2000
Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation.
    The Journal of clinical psychiatry, 2001, Volume: 62, Issue:3

    Topics: Acute Disease; Administration, Oral; Adult; Antipsychotic Agents; Drug Therapy, Combination; Emergency Services, Psychiatric; Female; Haloperidol; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Lorazepam; Male; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Risperidone; Treatment Outcome; Violence

2001
Adjunctive antipsychotic treatment of adolescents with bipolar psychosis.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2001, Volume: 40, Issue:12

    Topics: Adolescent; Antipsychotic Agents; Bipolar Disorder; Child; Drug Therapy, Combination; Female; Humans; Lithium; Lorazepam; Male; Psychiatric Status Rating Scales; Risperidone; Severity of Illness Index

2001
Bayesian pharmacokinetics of lithium after an acute self-intoxication and subsequent haemodialysis: a case report.
    Pharmacology & toxicology, 2002, Volume: 90, Issue:5

    Topics: Acute Disease; Acute Kidney Injury; Adult; Antimanic Agents; Antipsychotic Agents; Bayes Theorem; Bipolar Disorder; Drug Therapy, Combination; Fluoxetine; Humans; Lithium; Lorazepam; Male; Models, Biological; Renal Dialysis; Risperidone; Suicide, Attempted

2002
[Diphenhydramin-overdose: anticholinergic symptoms, EEG-findings in the course and drug treatment of a gerontopsychiatric patient].
    Psychiatrische Praxis, 2004, Volume: 31 Suppl 1

    Topics: Aged; Brain; Cholinergic Antagonists; Dementia; Depressive Disorder; Diphenhydramine; Drug Therapy, Combination; Electroencephalography; Histamine H1 Antagonists; Humans; Lorazepam; Male; Paranoid Disorders; Poisoning; Risperidone; Suicide, Attempted; Temazepam

2004
Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms.
    The journal of ECT, 2007, Volume: 23, Issue:4

    Topics: Administration, Oral; Adult; Aged; Antipsychotic Agents; Catatonia; Diazepam; Dose-Response Relationship, Drug; Electroconvulsive Therapy; Female; Haloperidol; Humans; Hypnotics and Sedatives; Infusions, Intravenous; Lorazepam; Male; Middle Aged; Retreatment; Risperidone; Schizophrenia, Catatonic; Treatment Outcome

2007
Neuroleptic malignant syndrome and catatonia in a patient with dementia.
    The Australian and New Zealand journal of psychiatry, 2008, Volume: 42, Issue:6

    Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Catatonia; Chlorpromazine; Cholinesterase Inhibitors; Cognition Disorders; Creatine Kinase; Dementia; Disease Progression; Donepezil; Female; Humans; Indans; Lorazepam; Muscle Rigidity; Neuroleptic Malignant Syndrome; Olanzapine; Piperidines; Recurrence; Risperidone

2008
Osteoporosis after combined use of a neuroleptic and antidepressants.
    Pharmacy world & science : PWS, 2008, Volume: 30, Issue:5

    Topics: Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Drug Interactions; Female; Humans; Lorazepam; Middle Aged; Osteoporosis; Prolactin; Rib Fractures; Risperidone; Sertraline

2008
Case of acute psychosis from herbal supplements.
    South Dakota medicine : the journal of the South Dakota State Medical Association, 2008, Volume: 61, Issue:5

    Topics: Acute Disease; Adult; Antipsychotic Agents; Dietary Supplements; Female; Haloperidol; Humans; Lorazepam; Plant Extracts; Psychoses, Substance-Induced; Risperidone; Treatment Outcome

2008
Postoperative psychosis in an adolescent subsequent to oral surgical outpatient procedure.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2009, Volume: 107, Issue:4

    Topics: Antipsychotic Agents; Dexamethasone; Female; Glucocorticoids; Humans; Injections, Intravenous; Lorazepam; Maxilla; Molar; Oral Surgical Procedures; Postoperative Complications; Psychoses, Substance-Induced; Radicular Cyst; Risperidone; Young Adult

2009
Risperidone-induced hyperamylasemia, hyperlipasemia, and neuroleptic malignant syndrome: a case report.
    Journal of clinical psychopharmacology, 2009, Volume: 29, Issue:4

    Topics: Antipsychotic Agents; Female; Humans; Hyperamylasemia; Injections, Intramuscular; Intubation, Gastrointestinal; Lipase; Lorazepam; Middle Aged; Neuroleptic Malignant Syndrome; Pancreatitis; Risperidone; Schizophrenia, Disorganized; Treatment Outcome; Urinary Catheterization

2009
[Catatonic dilemma in a schizoaffective patient with combined lithium-risperidone administration].
    Psychiatrische Praxis, 2010, Volume: 37, Issue:6

    Topics: Antimanic Agents; Antipsychotic Agents; Brain; Catatonia; Clozapine; Diagnosis, Differential; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Electroencephalography; Humans; Hypnotics and Sedatives; Lithium Carbonate; Long-Term Care; Lorazepam; Male; Middle Aged; Psychotic Disorders; Risperidone; Serotonin

2010
Electroconvulsive therapy in the treatment of delirious mania: a report of 2 patients.
    The journal of ECT, 2010, Volume: 26, Issue:4

    Topics: Adolescent; Antimanic Agents; Bipolar Disorder; Catatonia; Delirium; Electroconvulsive Therapy; Female; Humans; Hypnotics and Sedatives; Lithium Compounds; Lorazepam; Male; Psychotic Disorders; Risperidone; Secondary Prevention; Syndrome; Young Adult

2010
Risperidone and lorazepam concomitant use in clonazepam refractory catatonia: a case report.
    The Journal of nervous and mental disease, 2011, Volume: 199, Issue:12

    Topics: Catatonia; Clonazepam; Drug Therapy, Combination; Female; Humans; Lorazepam; Risperidone; Young Adult

2011
[Follow-up of a 16-year-old adolescent with early-onset schizophrenia and catatonic symptoms].
    L'Encephale, 2013, Volume: 39 Suppl 1

    Topics: Adolescent; Benzodiazepines; Carbamazepine; Clonazepam; Clozapine; Creatine Kinase; Diagnosis, Differential; Drug Resistance; Drug Substitution; Drug Therapy, Combination; Humans; Lorazepam; Male; Olanzapine; Patient Admission; Psychiatric Status Rating Scales; Psychometrics; Recurrence; Risperidone; Schizophrenia, Catatonic

2013
Electroconvulsive treatment in catatonia of cerebrovasculo-coagulopathy: a case report.
    The journal of ECT, 2013, Volume: 29, Issue:1

    Topics: Adult; Antipsychotic Agents; Catatonia; Cerebrovascular Disorders; Depression, Postpartum; Electroconvulsive Therapy; Female; GABA Modulators; Humans; Lorazepam; Nervous System Diseases; Risperidone; Thrombosis

2013
Influence of aripiprazole, risperidone, and amisulpride on sensory and sensorimotor gating in healthy 'low and high gating' humans and relation to psychometry.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014, Volume: 39, Issue:10

    Topics: Acoustic Stimulation; Amisulpride; Antipsychotic Agents; Aripiprazole; Auditory Perception; Benzhydryl Compounds; Brain; Double-Blind Method; Electroencephalography; Electromyography; Humans; Lorazepam; Male; Modafinil; Piperazines; Prepulse Inhibition; Psychometrics; Psychotropic Drugs; Quinolones; Risperidone; Sensory Gating; Sulpiride; Valproic Acid; Young Adult

2014
Neuroleptic malignant syndrome following abrupt anti-cholinergic withdrawal: a case report.
    Asian journal of psychiatry, 2014, Volume: 12

    Topics: Antipsychotic Agents; Cholinergic Antagonists; Female; Humans; Lorazepam; Neuroleptic Malignant Syndrome; Risperidone; Schizophrenia; Substance Withdrawal Syndrome; Trihexyphenidyl; Young Adult

2014
Treating an Adolescent with Long QT Syndrome for Bipolar Disorder: A Case Presentation.
    Psychopharmacology bulletin, 2017, 01-26, Volume: 47, Issue:1

    Topics: Adolescent; Bipolar Disorder; Female; Humans; Long QT Syndrome; Lorazepam; Risperidone; Valproic Acid

2017
Meditation induced psychosis: Case report.
    Asian journal of psychiatry, 2018, Volume: 31

    Topics: Adult; Antipsychotic Agents; GABA Modulators; Haloperidol; Humans; Lorazepam; Male; Meditation; Promethazine; Psychotic Disorders; Risperidone

2018
Cycloid psychosis and its longitudinal diagnosis: case report.
    Actas espanolas de psiquiatria, 2020, Volume: 48, Issue:1

    Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Female; Haloperidol; Humans; Hypnotics and Sedatives; Lorazepam; Psychotic Disorders; Recurrence; Risperidone; Sertraline; Sleep Initiation and Maintenance Disorders

2020
Overcoming Complications in Management of a Difficult-to-Treat Adolescent with Schizoaffective Disorder.
    Journal of child and adolescent psychopharmacology, 2020, Volume: 30, Issue:8

    Topics: Adolescent; Adolescent Psychiatry; Antidepressive Agents; Antipsychotic Agents; Diphenhydramine; Female; Haloperidol; Humans; Hypnotics and Sedatives; Lorazepam; Psychiatric Department, Hospital; Psychotic Disorders; Risperidone; Sertraline

2020
Brief psychotic disorder associated with quarantine and mild COVID-19.
    BMJ case reports, 2020, Dec-16, Volume: 13, Issue:12

    Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety Disorders; COVID-19; Humans; Lorazepam; Male; Mirtazapine; Pandemics; Psychotic Disorders; Qatar; Quarantine; Risperidone; SARS-CoV-2

2020
Case of paediatric catatonia precipitated by antipsychotic withdrawal in a child with autism spectrum disorder.
    BMJ case reports, 2021, Apr-23, Volume: 14, Issue:4

    Topics: Adolescent; Antipsychotic Agents; Autism Spectrum Disorder; Catatonia; Female; Humans; Lorazepam; Risperidone

2021
High-Dose Benzodiazepines in Treatment of Malignant Catatonia in an Adolescent: Lorazepam, Clonazepam, and Differing Efficacy.
    Journal of child and adolescent psychopharmacology, 2021, Volume: 31, Issue:6

    Topics: Adolescent; Anticonvulsants; Catatonia; Clonazepam; Humans; Lorazepam; Male; Risperidone; Treatment Outcome

2021